bw-755c has been researched along with sulfasalazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Hillier, K; Jones, DB; Pacheco, S | 1 |
| Burkart, V; Epstein, S; Kawai, K; Kiesel, U; Kolb, H; Maruta, K; Schmidt, M | 1 |
3 other study(ies) available for bw-755c and sulfasalazine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
The effect of sulphasalazine on the in vitro activation of human peripheral blood mononuclear cells by phytohemagglutinin P.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Dinoprostone; Humans; In Vitro Techniques; Indomethacin; Inflammatory Bowel Diseases; Leukocytes, Mononuclear; Phytohemagglutinins; Sulfasalazine | 1989 |
Modulation of arachidonic acid metabolism has limited effects on the development of type I diabetes in animal models.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Arachidonic Acid; Arachidonic Acids; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred BB; Sulfasalazine | 1989 |